LOXAPINE SUCCINATE - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for loxapine succinate and what is the scope of patent protection?

Loxapine succinate is the generic ingredient in two branded drugs marketed by Elite Labs Inc, Lannett Co Inc, Rising, Watson Labs, and Teva Branded Pharm, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for loxapine succinate. Six suppliers are listed for this compound.

Summary for LOXAPINE SUCCINATE

US Patents:	0
Tradenames:	2
Applicants:	5
NDAs:	8
Drug Master File Entries:	5
Finished Product Suppliers / Packagers:	6
Raw Ingredient (Bulk) Api Vendors:	88
Clinical Trials:	2
Patent Applications:	1,990
Drug Prices:	Drug price trends for LOXAPINE SUCCINATE
What excipients (inactive ingredients) are in LOXAPINE SUCCINATE?	LOXAPINE SUCCINATE excipients list
DailyMed Link:	LOXAPINE SUCCINATE at DailyMed

See drug prices for LOXAPINE SUCCINATE

Recent Clinical Trials for LOXAPINE SUCCINATE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Witten/Herdecke	Phase 2
Mylan Pharmaceuticals	Phase 1

See all LOXAPINE SUCCINATE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for LOXAPINE SUCCINATE

N05AH	Diazepines, oxazepines, thiazepines and oxepines
N05A	ANTIPSYCHOTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for LOXAPINE SUCCINATE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Rising	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076762-003	Nov 1, 2004		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-001	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Elite Labs Inc	LOXAPINE SUCCINATE	loxapine succinate	CAPSULE;ORAL	076868-004	Aug 4, 2005	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for LOXAPINE SUCCINATE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-001	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-003	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Teva Branded Pharm	LOXITANE	loxapine succinate	CAPSULE;ORAL	017525-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.